Centrexion’s small-molecule drug CNTX-0290 has a different mechanism to tanezumab, acting as a somatostatin receptor type 4 (SSTR4) agonist. SSTR4 is found on neurons and is thought to act as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback